Exploration of the utilization of irreversible cysteine protease inhibitor in FAP-targeted radiopharmaceuticals design to increase tumor residence time
{{output}}
Introduction: Fibroblast activation protein (FAP) is highly upregulated in the stroma of >90 % of epithelial cancers with restricted expression in normal tissues, making it an attractive drug target. Efforts by numerous laborator... ...
